{
    "ticker": "CTLT",
    "name": "Catalent, Inc.",
    "description": "Catalent, Inc. is a leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, and consumer health products. Founded in 2007 and headquartered in Somerset, New Jersey, Catalent operates across multiple segments including pharmaceuticals, biologics, and consumer health, enabling the development and commercialization of products that enhance patient outcomes. The company specializes in a wide array of services such as drug formulation, clinical supply, and manufacturing, with a focus on improving the efficiency and effectiveness of drug delivery. Catalent is recognized for its cutting-edge technologies, including its proprietary Zydis\u00ae fast-dissolve delivery system, which offers patients a convenient and effective method of drug administration. With a commitment to quality and innovation, Catalent partners with pharmaceutical and biotech companies to bring new therapies to market more quickly and efficiently. The company's mission is to help its partners deliver better treatments to patients while ensuring the highest standards of regulatory compliance and operational excellence.",
    "industry": [
        "Pharmaceuticals",
        "Biotechnology"
    ],
    "headquarters": "Somerset, New Jersey, USA",
    "founded": "2007",
    "website": "https://www.catalent.com",
    "ceo": "Alfred C. G. Altomari",
    "social_media": {
        "twitter": "https://twitter.com/Catalent",
        "linkedin": "https://www.linkedin.com/company/catalent",
        "facebook": "https://www.facebook.com/Catalent"
    },
    "investor_relations": "https://investors.catalent.com",
    "key_executives": [
        {
            "name": "Alfred C. G. Altomari",
            "position": "CEO"
        },
        {
            "name": "Marjorie S. M. B. O'Neill",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Pharmaceuticals",
            "products": [
                "Oral Solids",
                "Injectables",
                "Biologics"
            ]
        },
        {
            "category": "Consumer Health",
            "products": [
                "Nutraceuticals",
                "Over-the-Counter Products"
            ]
        }
    ],
    "seo": {
        "meta_title": "Catalent, Inc. | Advanced Delivery Technologies for Pharmaceuticals",
        "meta_description": "Explore Catalent, Inc., a leader in drug development and delivery solutions. Learn about our innovative technologies and commitment to improving patient outcomes.",
        "keywords": [
            "Catalent",
            "Pharmaceuticals",
            "Biologics",
            "Drug Delivery",
            "Zydis",
            "Clinical Supply"
        ]
    },
    "faq": [
        {
            "question": "What is Catalent known for?",
            "answer": "Catalent is known for its advanced delivery technologies and manufacturing solutions for pharmaceuticals and biologics."
        },
        {
            "question": "Who is the CEO of Catalent?",
            "answer": "Alfred C. G. Altomari is the CEO of Catalent, Inc."
        },
        {
            "question": "Where is Catalent headquartered?",
            "answer": "Catalent is headquartered in Somerset, New Jersey, USA."
        },
        {
            "question": "What are Catalent's main products?",
            "answer": "Catalent's main products include drug delivery systems, biologics, and consumer health products."
        },
        {
            "question": "When was Catalent founded?",
            "answer": "Catalent was founded in 2007."
        }
    ],
    "competitors": [
        "PFE",
        "ABBV",
        "AMGN",
        "BMY"
    ],
    "related_stocks": [
        "JNJ",
        "MRK",
        "GILD",
        "VRTX"
    ]
}